Technology has been accused of everything from spiraling anxiety to vanishing attention spans to social isolation. Now, it has something else on its charge sheet: Wrinkles. Behold “tech neck,” a name ...

Forbes contributors publish independent expert analyses and insights. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. This voice experience is generated by AI. Learn more. This ...

Genentech is halting development of an antibody for two rare genetic diseases after the candidate failed to boost muscle growth, raising questions about whether the molecule can preserve muscle in two ...

Since deep-learning super-sampling (DLSS) launched on 2018’s RTX 2080 cards, gamers have been generally bullish on the technology as a way to effectively use machine-learning upscaling techniques to ...

It’s the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster. Pharmaceutical giant Roche said today it is launching a new large-scale “AI factory ...

Genentech aims to build a portfolio of obesity treatments for unmet needs Xofluza flu medicine to be among next group of drugs on TrumpRx CEO hopes for 'a period of more predictability' in US health ...

The CEO of Roche's Genentech unit, Ashley Magargee, said on Monday (March 16) the company is striving to build a portfolio of obesity medicines that are both tolerable in terms of side effects as well ...

A once-rare engineering role has taken over Silicon Valley, promising to bridge the gap between cutting-edge artificial intelligence and the less tech-savvy customers who want to deploy it. But not ...

America will celebrate not just one, but two momentous anniversaries this year. Two hundred and fifty years ago, the Founding Fathers declared independence from Great Britain to protect Americans’ ...

When he started trading in 2020, Lito Chen followed mostly well-trodden advice, tucking his modest university student savings into the kinds of blue-chip stocks like liquor companies that analysts had ...

Novartis and Genentech are suing a U.S. company and a Canadian pharmacy over the importation of a Canadian version of their allergy medicine. The importation of the drug, which has strict shipping and ...

In 2020, immuno-oncology was at an inflection point. The first wave of PD1 blockers had shown that immune checkpoint inhibitors could be transformative for some cancer patients. But next-generation ...